Skip to main content
Clinical Trials/JPRN-UMIN000051140
JPRN-UMIN000051140
Completed
未知

Joint study on the development of preventive methods for active cardiovascular disease, cerebrovascular disease, and renal disease by vascular endothelial function examination(Second year continuation test) - Joint study of vascular endothelial function

HuBit genomix,Inc.0 sites341 target enrollmentJune 27, 2023
ConditionsONE

Overview

Phase
未知
Intervention
Not specified
Conditions
ONE
Sponsor
HuBit genomix,Inc.
Enrollment
341
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2023
End Date
September 3, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
HuBit genomix,Inc.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. If your arm tends to swell or bleed 2\. When a blood clot can form a blood clot 3\. When using antithrombotic agent 4\. When the blood clad can cause peripheral circulatory disorders 5\. If you are taking other medicines that affect blood vessels 6\. When the doctor judges that it is inappropriate due to poor physical condition etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Arita-cho Vascular Endothelial Function StudyONE
JPRN-UMIN000048118HuBit genomix,Inc.400
Recruiting
Phase 3
A study on the development of disease prevention education and health improvement program for customers by life insurance agent
JPRN-jRCT1020220037Mikami Tatsuya330
Recruiting
Phase 2
A phase 2 study, investigating prevention and treatment algorism of the skin toxicity related with Panitumumab treatment in patients with unresectable and/or metastatic CRC with KRAS wild type refractory to 5-FU containing chemotherapy
JPRN-UMIN000005862ational Cancer Center Hospital East40
Completed
Not Applicable
"This study on the preventive management of stomatitis due to everolimus treatment with steroid-containing mouthwash" examines the causal relationship between the oral microflora and onset of stomatitis.Renal cell carcinoma, Neuroendcrine tumors of pancreatic,lung and gastrointsitinaltract, Breast cancer
JPRN-UMIN000028106Department of Pharmacy,Aichi cancer center Faculty of Bioscience and Bioindustry,Tokushima University30
Completed
Not Applicable
"This study on the preventive management of stomatitis due to everolimus treatment with steroid-containing mouthwash" examines the causal relationship between drug metabolizing enzyme and onset of stomatitis.Renal cell carcinoma, Neuroendcrine tumors of pancreatic,lung and gastrointsitinaltract, Breast cancer
JPRN-UMIN000028110Department of Head and Neck Surgery, Pharmacy,Aichi cancer center Faculty of Pharmaceutical Sciences Suzuka University of MedicalScience Faculty of Bioscience and Bioindustry,Tokushima University30